Treatments

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Doxorubicin HCl with pluronic L-61 and pluronic F-127 Esophageal carcinoma Supratek Pharma Inc.;6100 Royalmount Avenue, Montreal;Quebec H4P 2R2 October 7, 2005
Dacetuzumab Chronic lymphocytic leukemia Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 October 6, 2005
Brivaracetam Symtomatic myoclonus UCB Pharma, Inc.;1950 Lake Park Drive;Smyra, Georgia, 30080 October 5, 2005
Imatinib mesylate Myeloproliferative disorders/myelodysplastic syndromes associated with platelet-derived growth factor gene re-arrangements Novartis Pharmaceuticals Corporation;One Health Plaza, Mail Code 105/1E870D;East Hanover, New Jersey, 07936 October 5, 2005
Fenretinide Neuroblastoma USC-CHLA Institute for Pediatric Clinical Research;Childrens Hospital of Los Angeles, 4650 Sunset Blvd, MS 55;Los Angeles, California, 90027 October 5, 2005
Brivaracetam Symtomatic myoclonus UCB Pharma, Inc.;1950 Lake Park Drive;Smyra, GA, 30080 October 5, 2005
Buthionine sulfoxamine Use as a modulator of chemotherapy for the treatment of pediatric patients with primary malignant brain tumors USC-CHLA Institute for Pediatric Clinical Research;Childrens Hospital of Los Angeles, 4650 Sunset Blvd, MS 55;Los Angeles, California, 90027 October 5, 2005
Buthionine sulfoxamine Neuroblastoma USC-CHLA Institute for Pediatric Clinical Research;Childrens Hospital of Los Angeles, 4650 Sunset Blvd, MS 55;Los Angeles, California, 90027 October 5, 2005
Chimeric monoclonal antibodies, c-alphaStx2 For treatment of shiga-toxin producing bacterial infection Taro Pharmaceuticals Inc.;130 East Drive;Brampton, Ontario October 4, 2005
Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131 Primary malignant brain tumors Bradmer Pharmaceuticals, Inc.;9900 Corporate Campus Drive, Suite 3000;Louisville, Kentucky, 40223 October 4, 2005
Patupilone Ovarian cancer Novartis Pharmaceutical Corporation;One Health Plaza;East Hanover, New Jersey, 07936 October 4, 2005
Recombinant Human Interleukin-21 (rIL-21) Stage II (T4), III or IV malignant melanoma Zymo Genetics, Inc;1201 Eastlake Avenue East;Seattle, Washington, 98102 October 4, 2005
Enzastaurin Glioblastoma Denovo Biopharma LLC;6331 Nancy Ridge Drive;San Diego, California, 92121 September 19, 2005
Masitinib Mastocytosis AB Science;3, avenue George V; September 14, 2005
Imatinib mesylate Systemic mastocytosis Novartis Pharmaceuticals Corporation;One Health Plaza, Mail Code 105/1E870D;East Hanover, New Jersey, 07936 September 9, 2005
Imatinib mesylate Idiopathic hypereosinophilic syndrome Novartis Pharmaceuticals Corporation;One Health Plaza, Mail Code 105/1E870D;East Hanover, New Jersey, 07936 August 25, 2005
Recombinant Epstein-Barr virus gp350 glycoprotein vaccine Prevention of post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation Henogen S.A.;Rue des Professeurs Jenner et Brachet, 12, B-6041-Gosselies; August 18, 2005
Recombinant anti-CD40 monoclonal antibody Chronic lymphocytic leukemia Novartis Pharmaceutical Corporation;Oncology Business Unit, One Health Plaza, Bldg 104;East Hanover, New Jersey, 07936 August 12, 2005
Balsalazide disodium Ulcerative colitis Salix Pharmaceuticals, Inc.;400 Somerset Corporate Blvd;Bridgewater, New Jersey, 08807 August 12, 2005
Alfentanil Painful HIV-associated neuropathy Cinergen, LLC;146 Medinah Drive;Blue Bell, Pennsylvania, 19422 August 9, 2005
Rapamycin (mTOR) inhibitor Bone sarcoma Merck Sharp & Dohme Corp.;S Merck & Co., Inc. Subsidiary, P. O. Box 1000, UG-2C50;North Wales, Pennsylvania, 19454 August 9, 2005
Biocarbonate infusate Use in the management of patients undergoing continuous renal replacement therapy with hemofiltration Dialysis Solutions, Inc.;14 Emmett Place, Whitby, Ontario L1R 2B4; August 9, 2005
Capsaicin Postherpetic neuralgia TheraQuest Biosciences, LLC;146 Medinah Drive;Blue Bell, Pennsylvania, 19422 August 3, 2005
Edotreotide Somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary);777 Old Saw Mill River Road;Tarrytown, New York, 10591 July 28, 2005
Nucleic acid aptamer binding to tumor cell nucleon Renal cancer Antisoma Inc.;300 Technology Square;Cambridge, Massachusetts July 28, 2005